Loading company…
Villanelle Life develops AI-based drug discovery and diagnostic platforms.
Villanelle Life uses AI and bioinformatics to research drug targets, early screening and companion diagnostics for cancer and cardiovascular conditions. Founded in 2021, the company is based in Shanghai, China. It raised Series A funding from Detong Capital in January 2026.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in